Wall Street Analysts Predict an 113.34% Upside in Avalo Therapeutics (AVTX): Here's What You Should Know

Average Wall Street price targets imply a 113.3% upside for Avalo Therapeutics (AVTX). The piece warns the price-target average is a questionable metric but notes a positive trend in earnings estimate revisions that could translate into upside for the stock. The view is speculative and likely won’t move the broader market without concrete fundamental or clinical catalysts.

Analysis

Average Wall Street price targets imply a 113.3% upside for Avalo Therapeutics (AVTX). The piece warns the price-target average is a questionable metric but notes a positive trend in earnings estimate revisions that could translate into upside for the stock. The view is speculative and likely won’t move the broader market without concrete fundamental or clinical catalysts.